Study title: A randomized, double blinded, parallel group, multicenter study to explore the pharmaco-kinetics, safety, tolerability and efficacy of tamsulosin in pediatric patients with signs and symptoms of dysfunctional voiding
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Urigenital diseases C12 and C13 | |||||
Brands: Please see report | |||||
MAH holders: Please see report | |||||
Assessment: | |||||
Active substance: TAMSULOSIN | |||||
ATC code: G04CA02 | |||||
Document link: 617-CL-310 Study synopsis_Tamsulosin.pdf | |||||
Document date: 2011-09-07 | |||||
Study number: 617-CL-310 | |||||
EudraCT number: | |||||
Scope of study: Clinical | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | - | - |